WATCH HealthTree University: Precursor Conditions (Part 3 of 3)

Every single person who gets myeloma first has a precursor condition. It is important to know how MGUS and SMM become active myeloma, and what you can do as a precursor condition patient to contribute to research about MGUS and SMM.

Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. We invite you to watch them all, and also visit HealthTree University and creating a HealthTree account. By creating a HealthTree account, in HealthTree University you can:

• Save and keep track of your progress in the courses
• Get points for answering quiz questions
• Bookmark videos
• Take notes
• Earn prizes [COMING SOON]
• And get access to all the other incredible features of HealthTree!

JOIN HEALTHTREE

8.11 What is the progression of myeloma from precursor conditions to active myeloma?

8.12 What is the PROMISE Study?

8.13 What is the PCROWD Study?

8.14 What is IgM MGUS?

We’d like to thank our faculty who donated their time in creating these videos, including:

• Irene Ghobrial, MD of Dana-Farber Cancer Institute

• Rafael Fonseca, MD of Mayo Clinic Scottsdale

• Jesus Berdeja, MD of Sarah Cannon Research Institute

Want more?

We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

Other HealthTree University Classes:

1 Myeloma Basics Part 1

2 Myeloma Basics Part 2

3 Myeloma Basics Part 3

4 Building Your Healthcare Team

5 Becoming an Empowered Patient

6 Starting Myeloma Treatment

7 Autologous Stem Cell Transplant (ASCT)

8 Precursor Conditions

9 Relapsed and Refractory MM Treatment

10 Know Your Therapy [BETA]

11 Myeloma Bone Disease

12 Blood and Urine Testing in Myeloma

13 Imaging in Myeloma

14 MRD Testing

15 Basic Genetics and Cancer Biology

16 Myeloma Genetics

17 Types of Genetic Testing in Myeloma

18 Classes of Drugs

19 COVID-19 and Multiple Myeloma [BETA]